The relentless efforts of scientists to exploit prevailing drugs, already in use to treat other disorders, and their value in impeding cognitive decline in Alzheimer's disease, has borne fruit.
Anti-hypertensive agents, now the cynosure of scientists' attention, offers promise in its perceived ability to offset cognitive decline and amyloid neuropathology, a foregone conclusion for patients afflicted with Alzheimer's.
The research spearheaded by Dr. Giulio Maria Pasinetti and colleagues at the Mount Sinai School of Medicine, is focused on certain anti-hypertensive drugs administered to the elderly, which might doubly benefit in preventing cognitive impairment.
'There is no convincing evidence that there is any available drug presently on the market to cure Alzheimer's disease and there are many questions surrounding the effectiveness of drugs that are available to delay or effectively alleviate symptoms of memory deterioration or dementia,' said Pasinetti.
Surely, this is an area which needs to be explored further, to draw additional benefits from existing cures.